BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 29652103)

  • 1. A 2-year prospective follow-up study of the course of obsessive-compulsive disorder.
    Eisen JL; Pinto A; Mancebo MC; Dyck IR; Orlando ME; Rasmussen SA
    J Clin Psychiatry; 2010 Aug; 71(8):1033-9. PubMed ID: 20797381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical choices can affect inferences about treatment efficacy: a case study from obsessive-compulsive disorder research.
    Simpson HB; Petkova E; Cheng J; Huppert J; Foa E; Liebowitz MR
    J Psychiatr Res; 2008 Jul; 42(8):631-8. PubMed ID: 17892885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unified protocol for the discontinuation of long-term serotonin reuptake inhibitors in obsessive compulsive disorder: Study protocol and methods.
    Boisseau CL; Rasmussen SA
    Contemp Clin Trials; 2018 Feb; 65():157-163. PubMed ID: 29306047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General personality dimensions, impairment and treatment response in obsessive-compulsive disorder.
    Samuels J; Bienvenu OJ; Krasnow J; Wang Y; Grados MA; Cullen B; Goes FS; Maher B; Greenberg BD; Mclaughlin NC; Rasmussen SA; Fyer AJ; Knowles JA; Mccracken JT; Piacentini J; Geller D; Stewart SE; Murphy DL; Shugart YY; Riddle MA; Nestadt G
    Personal Ment Health; 2020 May; 14(2):186-198. PubMed ID: 31859455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient adherence as a predictor of acute and long-term outcomes in concentrated exposure treatment for difficult-to-treat obsessive-compulsive disorder.
    Tjelle K; Opstad HB; Solem S; Kvale G; Wheaton MG; Björgvinsson T; Hansen B; Hagen K
    BMC Psychiatry; 2024 Apr; 24(1):327. PubMed ID: 38689256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective State Medicaid Claims Analysis of Children and Adults With Obsessive-Compulsive Disorder.
    Patel SR; Messner GR; Radigan M; Sang Y; Wang R; Gu G; Myers RW; Dixon LB; Simpson HB
    Psychiatr Serv; 2023 Nov; 74(11):1185-1188. PubMed ID: 37096356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term remission rates and trajectory predictors in obsessive-compulsive disorder: Findings from a six-year naturalistic longitudinal cohort study.
    Geiger Y; van Oppen P; Visser H; Eikelenboom M; van den Heuvel OA; Anholt GE
    J Affect Disord; 2024 Apr; 350():877-886. PubMed ID: 38266929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid Augmentation of Exposure-Based Psychotherapy for Obsessive-Compulsive Disorder.
    Kayser RR; Raskin M; Snorrason I; Hezel DM; Haney M; Simpson HB
    J Clin Psychopharmacol; 2020; 40(2):207-210. PubMed ID: 32068563
    [No Abstract]   [Full Text] [Related]  

  • 9. Associations of Autism Traits With Obsessive Compulsive Symptoms and Well-Being in Patients With Obsessive Compulsive Disorder: A Cross-Sectional Study.
    Doi S; Kobayashi Y; Takebayashi Y; Mizokawa E; Nakagawa A; Mimura M; Horikoshi M
    Front Psychol; 2021; 12():697717. PubMed ID: 34393929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute impact of COVID-19 pandemic on phenomenological features in fully or partially remitted patients with obsessive-compulsive disorder.
    Matsunaga H; Mukai K; Yamanishi K
    Psychiatry Clin Neurosci; 2020 Oct; 74(10):565-566. PubMed ID: 32697002
    [No Abstract]   [Full Text] [Related]  

  • 11. An Evaluation of Family-Based Treatment for OCD in Japan: A Pilot Randomized Controlled Trial.
    Kobayashi Y; Kanie A; Nakagawa A; Takebayashi Y; Shinmei I; Nakayama N; Yamaguchi K; Nakayama C; Hirabayashi N; Mimura M; Horikoshi M
    Front Psychiatry; 2019; 10():932. PubMed ID: 31998153
    [No Abstract]   [Full Text] [Related]  

  • 12. Remission and Relapse Across Three Years in Pediatric Obsessive-Compulsive Disorder Following Evidence-Based Treatments.
    Ivarsson T; Jensen S; Højgaard DRMA; Hybel KA; Torp NC; Melin K; Nissen JB; Weidle B; Thomsen PH; Dahl K; Skarphedinsson G
    J Am Acad Child Adolesc Psychiatry; 2024 May; 63(5):519-527. PubMed ID: 38070870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome in patients with obsessive-compulsive disorder after discontinuation of SRI treatment: results from a two-year follow-up.
    Kordon A; Kahl KG; Broocks A; Voderholzer U; Rasche-Räuchle H; Hohagen F
    Eur Arch Psychiatry Clin Neurosci; 2005 Feb; 255(1):48-50. PubMed ID: 15538591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obsessive-compulsive disorder: a 3-year prospective follow-up study of patients treated with serotonin reuptake inhibitors OCD follow-up study.
    Catapano F; Perris F; Masella M; Rossano F; Cigliano M; Magliano L; Maj M
    J Psychiatr Res; 2006 Sep; 40(6):502-10. PubMed ID: 16904424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment and management of treatment-refractory obsessive-compulsive disorder in children.
    Bloch MH; Storch EA
    J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):251-62. PubMed ID: 25791142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of compulsive hoarding.
    Saxena S
    J Clin Psychol; 2011 May; 67(5):477-84. PubMed ID: 21404273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-year follow-up study of Japanese patients with obsessive-compulsive disorder.
    Nakajima A; Matsuura N; Mukai K; Yamanishi K; Yamada H; Maebayashi K; Hayashida K; Matsunaga H
    Psychiatry Clin Neurosci; 2018 Jul; 72(7):502-512. PubMed ID: 29652103
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.